Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

August 31, 2005

Conditions

HIV Infections

Interventions

DRUG

Mifepristone

Trial Locations (10)

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

Univ. of Pennsylvania Health System, Presbyterian Med. Ctr., Philadelphia

Georgetown University CRS (GU CRS), Washington D.C.

Unc Aids Crs, Chapel Hill

The Ohio State Univ. AIDS CRS, Columbus

University of Washington AIDS CRS, Seattle

Harbor-UCLA Med. Ctr. CRS, Torrance

University of Minnesota, ACTU, Minneapolis

Washington U CRS, St Louis

Pitt CRS, Pittsburgh

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00099645 - Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People | Biotech Hunter | Biotech Hunter